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Abstract
Objective—To determine changes in average daily step count (ADSC) and 6-minute walk test
(6MWT) due to use of low-activity feet (LA) and high-activity energy-storage-and-return (ESAR)
feet, and examine the sensitivity of these measures to properly classify different prosthetic feet.
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Design—Individuals with transtibial amputations (n = 28) participated in a 6-week, randomized
crossover study. During separate 3-week periods, participants wore either a LA foot (eg, solidankle-cushioned-heel) or an ESAR foot. Differences in 6MWTand ADSC at the end of the 3-week
period were recorded.
Results—Subjects performed similarly in the 6MWTwith the LA and ESAR foot (P = 0.871) and
ADSC (P = 0.076). The correct classification of ESAR is only 51.9% and 61.5% with 6MWT and
ADSC, respectively. For the LA foot, correct classification is less than 50% for both tests.
Conclusions—Neither ADSC or 6MWT are responsive to changes in prosthetic feet. The
pitfalls and shortcomings of these instruments with regard to their ability to detect differences in
prosthetic feet are outlined. Based on these results, it is not recommended that the 6MWT and
ADSC are used as a means to assess outcomes for different prosthetic feet.
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In the most recent Cochrane Review on prosthetic ankle-foot prescription, Hofstad et al. 1
concluded that there is currently a lack of objective measures to support prosthetic
prescription. This may be guided by an inability to currently identify the best means by
which to assess prosthetic rehabilitation outcomes. The criterion standard of gait assessment
is considered to occur within the motion analysis laboratory setting with high-speed cameras
and force plate technology. The combination of cameras and force plates can provide
numerous spatial-temporal (eg, time and distance), kinematic (eg, joint and segmental
motion), and kinetic (eg, force, moment, power, and work) measures. The use of such a
laboratory in prosthetic rehabilitation has clinical limitations owing to financial obligations
and time restrictions. As a result, there has been a strong emphasis on establishing measures
that are able to determine the best care for patients without the need for a motion analysis
laboratory. This study will particularly focus on patients requiring the use of lower limb
prostheses.
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One such measure that has been translated into prosthetic rehabilitation from other
pathologies is the 6-minute walk test (6MWT). The 6MWT came into existence in the early
1980s when Butland et al.2 showed the test was as reliable as its longer predecessor, the 12minute walk test. It was initially used to monitor cardiac rehabilitation patients in which the
primary concern was capacity for physical activity.2–5 The popularity of the 6MWT in
prosthetic rehabilitation seemingly increased after it was reported to provide good
classification for individuals with lower limb amputation with regard to their Medicare
Functional Classification Level (MFCL).6 The MFCL system is the United States’
classification system that groups individuals with lower limb amputation into 5 different
categories referred to as K-levels.6,7 Whereas discrimination between all the various
classification levels is important for providing a prosthesis with regard to reimbursement, the
most critical distinction occurs between K2- and K3-level ambulators. The Centers for
Medicare Services and private insurance companies place no restrictions on the types of
prosthetic feet that will be reimbursed for individuals that are classified as K3-level
ambulators (with the exception of sport specific feet).7 The Centers for Medicare Services
and private insurance companies, however, will not reimburse carbon fiber feet technology
for individuals classified as K2 or lower.
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The use of the 6MWT has grown in popularity as a tool to help correctly identify an
individual’s MFCL status.8,9 However, the use of 6MWT to classify differences in
performance due to prosthetic componentry is not supported. Gailey et al.8 showed no
significant difference in 6MWT for a group of subjects (n = 10) wearing a prosthesis with 4
different types of feet, 2 of which were K2 level and 2 of which were K3 level. Despite their
limited sample size, this study provided strong findings discouraging use of 6MWT for
outcomes assessment in prosthetic rehabilitation.
More recent technological developments have resulted in the potential use of step activity
monitoring to record average daily step count (ADSC) to determine functional level of
individuals with lower limb amputation.10,11 Proponents of ADSC feel it gives the clinician/
researcher the ability to determine an individual’s functionality outside of a laboratory
setting as well as provide a functional description less prone to error from day-to-day
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variations that may influence measures captured in a single-day visit. Average daily step
count uses accelerometers that are able to record the number of steps throughout the day
based on acceleration spikes. Despite the early excitement and recommendations of ADSC
use in prosthetic rehabilitation, studies suggest a level of futility with ADSC for prosthetic
outcomes. Gailey et al.8 also recorded step counts to accompany 6MWT and found no
response to changes in prosthetic feet. In fact, individuals with K2 feet took more steps on
average through the day compared to the K3 feet.8 Klute et al.12 examined the effects of
prosthetic knee joints on daily step activity and failed to find any significant difference
between a microprocessor knee joint and a nonmicroprocessor knee joint. These findings
contradict recommendations for ADSC use for outcomes assessment in prosthetic
rehabilitation.
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The 6MWT and ADSC have primarily been used to properly classify the individual’s
functional status.6,9–11,13 However, to be an effective outcomes assessment tool, the measure
needs to be responsive to different prosthetic components. Showing differences due to
prosthetic components is critical, as this is the factor that is being reimbursed within the US
payer system. In other words, only showing a patient has a certain functional status does not
truly justify the use of certain prosthetic technologies if ultimately they will perform the
same with any prosthesis and components. Therefore, the purpose of this study was 2-fold:
first, to determine the impact of 2 activity levels of prosthetic feet on 6MWT and ADSC;
and second, to determine the feasibility of these 2 measures (6MWT and ADSC) in
distinguishing between prosthetic feet by examining the measures’ ability to properly
classify each foot. It was hypothesized that despite persistent recommendations for the use
of 6MWT and ADSC, these measures would not be responsive to different prosthetic feet or
able to be used to differentiate prosthetic feet.
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METHODS
Participants
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To be included in the study, participants needed to have had their current prosthesis longer
than 30 days and be able to commit to a 6-week protocol. Participants were excluded if any
ulcers were present on either the residual limb or contralateral limb or if they were unable to
provide informed consent owing to cognitive conditions. The presence of any major
neuromuscular or musculoskeletal conditions affecting walking (eg, stroke, Parkinson
disease, multiple sclerosis) would also prevent inclusion to assure the primary diagnosis
afflicting the person’s ambulatory status was amputation of the lower extremity. Finally, all
participants needed to be currently wearing a satisfactorily fitting endoskeletal-type
prosthesis that would permit swapping prosthetic feet.
Procedures
Subjects participated in a randomized 6-week crossover study. Individuals were initially
randomly assigned to begin wearing either a low-activity foot (LA foot; eg, solid-anklecushioned-heel [SACH] foot) or a high-activity energy-storage-and-return (ESAR) foot. The
LA feet are either classified as having a rigid or flexible keel according to the testing and
classification standards presented within the American Orthotics and Prosthetics
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Association’s Prosthetic Foot Project.14 The ESAR feet used are all classified as dynamic
keel.14 The Prosthetic Foot Project clearly states that the measurement and categorization of
the mechanical properties of the feet does not constitute clinical standards or effectiveness of
the prosthetic feet when applied to specific patients.14 The Prosthetic Foot Project does,
however, provide mechanical properties of the feet, which is then used to assign payer codes.
Prosthetic feet with rigid or flexible keel classification are designed to be prescribed for
functional levels K2 or lower; a dynamic keel classification is designed to be prescribed for
functional levels K3 or higher.14 These distinct mechanical classification and functional
classification differences guaranteed mechanical and clinical differences in components
being worn by subjects. After assignment of the subject to either the LA or ESAR foot, the
subjects’ current prosthetic foot was removed and replaced. The patient’s height, weight,
and residual limb length were used to appropriately select the LA and ESAR foot for each
subject. The subject’s socket and suspension previously prescribed and fabricated by their
prosthetist was used to mitigate confounders from socket fit and suspension. The prosthesis
was then properly aligned by a certified prosthetist. A step activity monitora was attached to
the subject’s pylon and covered in a binding material to prevent dislocation. The subject then
wore the prosthesis for 3 weeks, coming to the laboratory every 1.5 weeks to download data
and recharge the monitor. At the end of the initial 3-week wear period, subjects performed a
6MWT. During the 6MWT, subjects were not given encouragement, as this can substantially
affect total distance walked.3 After the 6MWT, the prosthetic foot was switched and another
3-week period was repeated with the same protocol. Importantly, the prosthesis was properly
aligned again, after the foot was switched by the same prosthetist. During each 3-week
period, participants were given no specific instructions for activity.

Author Manuscript
Author Manuscript

The ADSC was recorded for each 3-week period excluding the days the person came to the
laboratory. Participants were subjected to other tests on the days they were in the laboratory
as part of additional studies; and as a result, these days did not reflect their typical activities
of daily living. These studies’ findings are reported elsewhere. Differences in ADSC for the
different prosthesis setups and total distance for the 6MWT were tested through a dependent
t test with an alpha level set to 0.05, and the corresponding 95% confidence intervals were
calculated. Profile and agreement plots were generated as visualizations of the agreement
between the measures taken under differing setups. A generalized linear mixed model for a
binary outcome with logit link was used to summarize the classification ability of these tests
while accounting for the correlation due to measurements on the same individual. Prosthesis
was the dependent variable with separate models fit for 6MWT and ADSC as the
independent variable.
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RESULTS
Twenty-eight individuals with transtibial-level amputation provided written consent
according to University Medical Center Institutional Review Board–approved protocol
procedures. Twenty-four of the participants were unilaterally affected, whereas 4 had
bilateral transtibial level amputations (Table 1). All individuals were previously classified by
their physician and prosthetist as K3- or K4-level ambulators (ie, high activity, community
aActigraph, 49 East Chase St, Pensacola, FL 32502
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ambulators, capable of various walking speeds). Subjects’ prescribed prosthetic feet were
consistent with this classification (Table 2). Average daily step count (ADSC) could only be
obtained from 26 subjects owing to malfunction of the monitor. One individual refused to
complete the 6MWT. For the 6MWT, individuals showed no significant difference in
walking distance when walking with a LA foot or an ESAR foot (P = 0.871; 95% confidence
interval: −17.5 to 20.5 m; Table 3). Results for ADSC were similar. The ADSC showed no
significant difference when walking with the higher-activity ESAR foot compared to the LA
foot (P = 0.076; 95% CI, −33.7 to 623.8 steps). As shown in the profile and agreement plots,
measures were nearly identical for most participants under both conditions (Figs. 1, 2). The
heterogeneity of ESAR feet prevented any notable trends specific within any make or model
of ESAR feet. Figure 3 depicts the predicted probability of being classified as ESAR by
using the 6MWT or ADSC measure, and is plotted against its respective measure from
which the probability is calculated (ie, either 6MWT or ADSC). If either were good
classification tools, we would begin to see some separation between symbols with increase
in the independent variable. However, as clearly shown in Figure 3, there is no separation of
devices based on 6MWT and ADSC. Using a cutoff probability of 0.5, the correct
classification of ESAR is only 51.9% and 61.5% with 6MWT and ADSC, respectively. For
the LA Foot, correct classification is less than 50% for both tests.

DISCUSSION
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Despite previous work showing differences in activity level of patients when measuring
either 6MWTor ADSC,6,9–11,13 this was not the case for changes in the prosthetic foot. This
is concerning, as the prosthetic foot represents a major component of a prosthesis, both in
functionality and cost. If neither measure is responsive to changes with a major component,
it is doubtful that smaller componentry would warrant any response thereby questioning the
value of these measures in prosthesis outcomes assessment. In the current study, neither
measure was adequate to distinguish prosthetic feet; measurements were nearly identical for
most subjects under both conditions (Fig. 1). Whereas results for ADSC may be approaching
significance, it should be noted that ADSC was greater when participants wore the LA feet,
consistent with Gailey et al.8 From Figures 1 and 2, it is noted that there is a nearly equal
split with regard to some individuals increasing their ADSC and 6MWT with the use of
ESAR feet, whereas some decreased. Because of this, we would not expect any cumulative
effect to influence the results such that perhaps a 12-minute walk test would have different
results. However, this was not tested. Based on the current results, ADSC would make it
more difficult to justify the use of more expensive carbon fiber feet in K3-level patients, as it
may promote decreased activity. This conclusion would seem counter to clinical impressions
from such feet.
The prosthesis, or specifically within this study, the prosthetic foot, is a mechanical device
attempting to replace the biomechanics of the amputated limb. There are multiple influences
beyond the characteristics of the prosthesis that can affect the 6MWT and ADSC. Included
in these considerations are physical fitness and self-efficacy, as evidenced by the initial body
of work using the 6MWT in cardiac rehabilitation and obesity.3–5,18 Ultimately, the problem
with the 6MWT and ADSC for prosthesis outcomes assessment may be the global nature by
which the task is accomplished. There are many factors (eg, strength, range of motion,
Am J Phys Med Rehabil. Author manuscript; available in PMC 2017 November 01.
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neuromuscular control, cardiovascular reserve, motivation, biomechanics of the person and
prosthesis, etc.) that affect the task of movement. With so many factors affecting
performance, individuals can reweight and rely more heavily on other factors in the presence
of any deficiencies. A prosthesis only directly changes the biomechanics. Hence, if an LA
foot is used on a high-activity individual, they can use more of the available strength and
range of motion to potentially increase compensations. They are more likely to have the
available neuromuscular control to manage to quickly adapt and accomplish the task. As a
result, the impact of the prosthesis may not be detected by the 6MWT and ADSC. It thus
needs to be considered what is being measured and what we as prosthetists desire to
measure. A prosthetist is trained to fit a prosthesis, and then perform observational gait
analysis, followed by realignment to alter the biomechanics of the prosthesis to minimize
gait deviations. This overly simplified process should be the root of any attempt at outcomes
assessments. In other words, we need to consider what are the most pervasive gait deviations
and altered biomechanics and attempt to record these outcomes. There should be focus on
assessing quality of gait, not quantity. Prosthetists have known for decades that these are the
end points of concern, yet we are seeing increased recommendations of measures that do not
directly measure gait deviations and altered biomechanics. Biomechanics are not measured
by 6MWT and ADSC. As an example, consider the lone subject that refused to do 6MWT.
The subject had a body mass index of 44.3, was considered morbidly obese, and was also a
smoker. Walking from the parking lot to the laboratory required breaks for this person.
These details all highlight the subject’s poor physical fitness. However, when the subject
performed detailed gait analysis,15–17 the lower limb joint moments and joint powers were
consistent with the other participants in the study, which were also K3-level ambulators. In
this subject’s case, physical fitness and self-efficacy are limiting factors in the 6MWT, and
the mechanics of the prosthetic foot are not a factor. This person was able to ambulate with
variable cadence, a key descriptor for Medicare K3-level classification.6–8 In addition, she is
a “community ambulator who has the ability to traverse most environmental barriers” and
has vocational activities that require prosthetic use beyond simple walking.7 Yet, if we were
to endorse the use of 6MWT, this patient would not have qualified for the higher-technology
prosthetic foot she uses.

Author Manuscript

Even more problematic may be the use of ADSC. A person’s activity through the day is
largely dictated by that person’s routine. If an individual awakes in the morning and
performs their daily routine, a device will have minimal effect on changing the person’s
desire to do this. Changing the prosthesis will change the biomechanics of the
individual.19–26 More specifically, the prosthetic foot can affect step length.24 If an
individual has a certain routine through the day, the individual walks the same distance each
day as part of the routine. The step length afforded by the mechanics of the prosthetic foot
will dictate how many steps are needed to cover that same distance. An example of this is
the bilateral subject that participated in this study whose K3 feet were the only currently
commercially available powered ankle-foot systemj. The primary mechanical difference in
this powered ankle-foot system is its increased ankle power output in late stance during push
off. Beyond that, the foot is built on a traditional ESAR foot platform (Variflexd). As a

jBiom, 4 Crosby Dr, Bedford, MA 01730
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result, other benefits of ESAR feet should be expected as well.23,24 A major noted finding of
ESAR feet over LA feet such as SACH is the late-stance energy return (hence the acronym
ESAR).14 Thus, from a mechanical perspective, the ankle-foot system represents an ESAR
foot with an increased positive energy profile in late stance, further exaggerating known
mechanical differences between ESAR and SACH feet used in this study for purposes of
improving the ability to detect differences. The individual’s ADSC when wearing the
powered ankle-foot system was 4,432.2 steps, but when wearing bilateral SACH feet, he
averaged 4,973.4 steps per day. Yet, in the detailed gait analysis as part of the larger study,
the subject’s step length when wearing bilateral SACH feet was, on average, 0.592 m but
0.699 m for the powered ankle-foot system. Using rough approximations, this would
indicate that the subject covered approximately 2,944.3 m/d when wearing the bilateral
SACH but 3,098.1 m/d for the bilateral powered ankle-foot system. Despite limitations with
this generalized calculation, this distance covered does support increased activity with a
higher activity foot. Therein lies not only the major limitation of ADSC but also the possible
erroneous conclusions that could be drawn by simply looking at the number of steps taken in
a day. Average daily step count does not account for quality of gait. The inclusion of
patient’s step length may improve results from ADSC, or, alternatively, step activity
monitors are being equipped now with the ability to determine different activities based on
pattern recognition algorithms, which may also provide more responsive outcomes
assessments.
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It should be noted that this study enrolled individuals that were K3-/K4-level ambulators for
ease of recruitment, and then “downgraded” the patients to a lower–activity level foot
component. These results, however, should not necessarily be considered applicable in the
scenario of a lower-level ambulator that is using a higher activity level foot component. In
particular, the results noted within this study may actually be highlighting a ceiling effect for
6MWT and ADSC whereby the positive impact of high-activity feet may not be a large
enough factor to deter daily activity of K3-/K4-level ambulators. On the other hand, the
positive attributes of high-activity feet may be enough to motivate increased daily activity
detectable via 6MWT and ADSC among lower-level ambulators. This will need to be further
explored. Consistent with previous discussion, it is possible that low-level ambulators do not
have the available resources (eg, strength, range of motion, neuromuscular control,
cardiovascular reserve, motivation, etc.) to effectively reweigh such factors and overcome
deficiencies and need every bit of added biomechanical advantage from ESAR feet.23
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Finally, there is the possibility that the reason the ADSC and 6MWTwere not sensitive
enough to detect a difference between the prosthetic feet may reflect an actual lack of
differences. It seems unlikely given the body of literature that supports ESAR feet over
simpler feet such as SACH feet, but it is a possibility worth considering. However, this may
be a limitation of the study population, which was entirely composed of K3 or higher
ambulators. By definition, these individuals are more active and it is possible that these
participants were able to compensate and overcome deficits imposed by the lower-activity
foot. Future work should expand to examine K2 ambulators.

dOssur, 27051 Towne Centre Dr, Foothill Ranch, CA 92610
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There are limitations to this study. First, the timeframe under which subjects were monitored
for ADSC needs to be considered. Three weeks was chosen as the period because this has
been outlined as an adequate adaptation period,27 and thus, it was felt that the measure of the
6MWT at the end of such a period would overcome the limitation of adaptation. This,
however, does not exclude ADSC from being influenced by adaptation or learning, as the
individual may have experienced more dramatic changes through the 3-week period
depending on the device, which could influence the outcomes. However, the use of an initial
3-week period has clinical attractiveness because it falls under the 30-day trial period that
many prosthetic foot manufacturers offer on prosthetic feet purchases. Three weeks is also
likely not long enough for biomechanical differences in prosthetic components to influence
other factors such as physical fitness and self-efficacy, which may lead to improved response
in 6MWT and ADSC. It should be noted though that Gailey et al.8 used an 8-week period
and failed to find differences. This raises the questions of how long a time period would be
necessary to see differences in ADSC or 6MWT due to prosthesis difference, and if such a
period would be pertinent to prosthetic rehabilitation where the typical prosthesis has a 3year warranty and then should be considered for replacement for safety reasons to prevent
failure.
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Furthermore, all participants had a history of prosthetic use, and it is unclear what impact
their experience with previously using ESAR feet may have had on the current findings.
However, it would seem that this would negatively influence their performance on the foot
that was least like the foot they had more experience using, but results showed performance
on the LA feet were similar to the ESAR feet according to ADSC and 6MWT. Next, we
assumed that the manufactured feet are characterized correctly, such that the ESAR feet are
truly “higher activity”. The ESAR feet are classified as dynamic response type of feet with a
skeleton of carbon fiber (or similar material with high passive energy return properties). It is
possible these feet are not truly higher-activity level, although this would seem to be more of
a nomenclature problem and perhaps the feet should be more appropriately described by
their mechanical properties such as energy return.23
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In addition, we used multiple make and models of ESAR feet to best accommodate patient
weight and limb length. This heterogeneity within ESAR feet prevented any possible trends
of performance specific to any manufacturer or specific model. Additionally, this study
relied on classification of patients according to MFCL. It seems more reasonable that the
millions of individuals with amputation would fall into a spectrum of functional or activity
levels. For example, the ADSC for the 27 individuals in this study had a range of average
steps from 2,393.6 to 9,626.1. Additionally, whereas the accelerometer has shown good
reliability for step count detection,28 step counts are based on accelerations for nonprosthetic
ambulation. Increased accelerations may be possible with prosthetic ambulation causing
artifacts in step count calculation.
Finally, walking speed continues to gain popularity as an outcome measure. Walking speed
was not included as an outcome measure in this study, although it may have been more
sensitive than ADSC and 6MWT. However, walking speed will factor into 6MWT, and the
pervasive lack of differences in 6MWTwould not lend itself to the thought that walking
Am J Phys Med Rehabil. Author manuscript; available in PMC 2017 November 01.
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speed would detect differences in a population that will not be as hindered by fatigue as
lower-level ambulators. This should be tested in future work comparing feet, however,
before any conclusions are made.

CONCLUSION
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The use of 6MWT and ADSC may provide good descriptions of a lower limb prosthesis
user’s functional ability. However, these measures do not account for many factors that go
into an individual’s functionality. As such, in the case of prosthetic rehabilitation, the
prosthetic foot type does not affect the 6MWTand ADSC for K3-/K4-level ambulators
despite known differences in LA and ESAR feet.19,24,27 Failure to account for the
biomechanical function of prosthetic feet yields a lack of differences in 6MWT or ADSC or,
even possibly, results that could lead to detrimental interpretation. Clinicians are cautioned
against using 6MWT and ADSC to assess prosthetic outcomes for K3-/K4-level ambulators.

Acknowledgments
This work was supported through funds from the Orthotic and Prosthetic Education and Research Foundation, Inc.
(OPERF) (OPERF-2012-FA-2), American Society of Biomechanics Grant-In-Aid Award, AAHPERD Research
Consortium Doctoral Grant, and a UNMC Widaman Graduate Fellowship. The authors acknowledge Mr. Jeff
Kaipust, MS, for his assistance with data collection.
The authors acknowledge Mr Jeff Kaipust, MS, for his assistance with data collection.

References

Author Manuscript
Author Manuscript

1. Hofstad C, Linde H, Limbeek J, et al. Prescription of prosthetic ankle-foot mechanisms after lower
limb amputation. Cochrane Database Syst Rev. 2004:CD003978. (updated 2009). [PubMed:
14974050]
2. Butland RJ, Pang J, Gross ER, et al. Two-, six-, and 12-minute walking tests in respiratory disease.
Br Med J (Clin Res Ed). 1982; 284:1607–8.
3. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance.
Thorax. 1984; 39:818–22. [PubMed: 6505988]
4. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise
capacity in patients with chronic heart failure. Can Med Assoc J. 1985; 132:919–23. [PubMed:
3978515]
5. Guyatt GH, Thompson PJ, Berman LB, et al. How should we measure function in patients with
chronic heart and lung disease? J Chronic Dis. 1985; 38:517–24. [PubMed: 4008592]
6. Gailey RS, Roach KE, Applegate EB, et al. The amputee mobility predictor: an instrument to assess
determinants of the lower-limb amputee’s ability to ambulate. Arch Phys Med Rehabil. 2002;
83:613–27. [PubMed: 11994800]
7. Local Coverage Determination. [Accessed August 9, 2014] Lower Limb Prostheses [homepage on
the Internet]. Noridian Medicare. 2014. [cited Aug 9, 2014]. Available from: https://
www.noridianmedicare.com/dme/coverage/docs/lcds/current_lcds/lower_limb_prostheses.htm
8. Gailey RS, Gaunaurd I, Agrawal V, et al. Application of self-report and performance-based outcome
measures to determine functional differences between four categories of prosthetic feet. J Rehabil
Res Dev. 2012; 49:597–612. [PubMed: 22773262]
9. Resnik L, Borgia M. Reliability of outcome measures for people with lower-limb amputations:
distinguishing true change from statistical error. Phys Ther. 2011; 91:555–65. [PubMed: 21310896]
10. Halsne EG, Waddingham MG, Hafner BJ. Long-term activity in and among persons with
transfemoral amputation. J Rehabil Res Dev. 2013; 50:515–30. [PubMed: 23934872]

Am J Phys Med Rehabil. Author manuscript; available in PMC 2017 November 01.

Wurdeman et al.

Page 10

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

11. Orendurff, MS., Rosenbaum-Chou, T., Kobayashi, T., et al. Functional level assessment using
wearable sensor data: experienced gait experts versus a calculated estimate. Proceedings of the
17th Annual Gait & Clinical Movement Analysis Society Meeting; May 2012; Grand Rapids, MI.
2012. p. 306-7.
12. Klute GK, Berge JS, Orendurff MS, et al. Prosthetic intervention effects on activity of lowerextremity amputees. Arch Phys Med Rehabil. 2006; 87:717–22. [PubMed: 16635636]
13. Raya MA, Gailey RS, Fiebert IM, et al. Impairment variables predicting activity limitation in
individuals with lower limb amputation. Prosthet Orthot Int. 2010; 34:73–84. [PubMed:
20196689]
14. AOPA. AOPA Prosthetics Foot Project Report. Alexandria, VA: American Orthotics & Prosthetics
Association; 2010. p. 1-44.
15. Kent JA, Stergiou N, Wurdeman SR. Step activity and stride-to-stride fluctuations are negatively
correlated in individuals with transtibial amputation. Clinical Biomechanics. 2015; 30:1225–9.
[PubMed: 26319219]
16. Wurdeman SR, Myers SA, Stergiou N. Amputation effects on the underlying complexity within
transtibial amputee ankle motion. Chaos. 2014; 24:013140. [PubMed: 24697402]
17. Wurdeman, SR., Seeley, SM., Jacobsen, AL., et al. Improved gait symmetry following amputeespecific physical therapy. American Academy of Orthotists & Prosthetists 2015 Annual Scientific
Meeting and Symposium; New Orleans, LA. 2015;
18. Capodaglio P, De Souza SA, Parisio C, et al. Reference values for the 6-min walking test in obese
subjects. Disabil Rehabil. 2013; 35:1199–203. [PubMed: 23061440]
19. Lehmann JF, Price R, Boswell-Bessette S, et al. Comprehensive analysis of dynamic elastic
response feet: Seattle Ankle/Lite foot versus SACH foot. Arch Phys Med Rehabil. 1993; 74:853–
61. [PubMed: 8347071]
20. Fradet L, Alimusaj M, Braatz F, et al. Biomechanical analysis of ramp ambulation of transtibial
amputees with an adaptive ankle foot system. Gait Posture. 2010; 32:191–8. [PubMed: 20457526]
21. Alaranta H, Kinnunen A, Karkkainen M, et al. Practical benefits of Flex-Foot in below-knee
amputees. J Prosthet Orthot. 1991; 3:179–81.
22. Barr AE, Siegel KL, Danoff JV, et al. Biomechanical comparison of the energy-storing capabilities
of SACH and Carbon Copy II prosthetic feet during the stance phase of gait in a person with
below-knee amputation. Phys Ther. 1992; 72:344–54. [PubMed: 1631203]
23. Hafner BJ, Sanders JE, Czerniecki JM, et al. Transtibial energy-storage-and-return prosthetic
devices: a review of energy concepts and a proposed nomenclature. J Rehabil Res Dev. 2002;
39:1–11.
24. Sagawa Y Jr, Turcot K, Armand S, et al. Biomechanics and physiological parameters during gait in
lower-limb amputees: a systematic review. Gait Posture. 2011; 33:511–26. [PubMed: 21392998]
25. Wurdeman SR, Myers SA, Jacobsen AL, et al. Adaptation and prosthesis effects on stride-to-stride
fluctuations in amputee gait. PLoS One. 2014; 9:e100125. [PubMed: 24956384]
26. Wurdeman, SR. Dissertation. University of Nebraska Medical Center; 2013. Stride-to-stride
fluctuations are related pre/post adaptation for an appropriate prosthesis. Quantifying stride-tostride fluctuations in amputee gait: implications for improved rehabilitation.
27. English RD, Hubbard WA, McElroy GK. Establishment of consistent gait after fitting of new
components. J Rehabil Res Dev. 1995; 32:32–5. [PubMed: 7760265]
28. Silva P, Mota J, Esliger D, et al. Technical reliability assessment of the actigraph GT1M
accelerometer. Meas Phys Educ Exerc Sci. 2010; 14:79–91.

Am J Phys Med Rehabil. Author manuscript; available in PMC 2017 November 01.

Wurdeman et al.

Page 11

Author Manuscript
FIGURE 1.
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Profile plots for 6MWT (A) and ADSC (B).
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FIGURE 2.

Agreement plots for 6MWT (A) and ADSC (B).
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FIGURE 3.
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Predicted probability of ESAR based on 6MWT (A) and ADSC (B).
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177.4 ± 8.0

53.6 ± 11.3

98.4 ± 19.3

Mass (kg)
8.3 ± 9.2

Time Since Amputation (yrs)

All participants were above MFCL K2 level. Mean ± SD.

Height (cm)

Author Manuscript

Age (yrs)
16.3 ± 4.4

Residual Limb Length (cm)
16 trauma, 8 vascular/diabetes, 2 cancer, 2 infection

Cause of Amputation

Author Manuscript

Subjects’ demographics
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TABLE 2

Author Manuscript

Models of prosthetic feet prescribed to each patient, as well as the feet used within the study
LA Foot (Rigid or Flexible Keel14)

ESAR Foot (Dynamic Keel14)

Author Manuscript
Author Manuscript

Subject ID

Prescribed Foot

1

Echelonb*

SACHc

Echelonb

2

Reflex Rotated

SACHc

Renegadee

3

Soleus f

SACHc

Variflexd

4

Renegadee

SACHc

Fusionc

5

Variflexd

SACHc

Fusionc

6

Triasg

SACHc

Senatore

7

Variflexd

SACHc

Fusionc

8

Reflex Rotated

SACHc

Duralitec

9

Reflex Rotated

SACHc

Renegadee

10

Sierrae

SACHc

Biom j

11

Echelonb

SACHc

Fusionc

12

Tribute f

SACHc

Fusionc

13

Reflex Rotated

SACHc

Duralitec

14

Soleus f

SACHc

Renegadee

15

Taluxd

SACHc

Variflexd

16

Variflexd

Walkteke†

Rush87i

17

Epirusb

SACHc

Senatore

18

Assured

SACHc

Rush87i

19

Sierrae

SACHc

Renegadee

20

Trustep f

SACHc

Pacificae

21

LP Variflexd

SACHc

Pacificae

22

Reflex Rotated

SACHc

Rush87i

23

Trustep f

SACHc

Fusionc

24

Renegadee

SACHc

Senatore

25

Axtiong

SACHc

Renegadee

26

Sure-flexd

SACHc

Eliteb

27

Catalysth

SACHc

Senatore

28

Trustep f

SACHc

C-Walkg

Author Manuscript

All LA feet are either rigid or flexible keels, ESAR feet are dynamic keels.14

*
Subject’s initial use of prescribed foot coincided with study, subject had no prior experience with the foot.
†

The Walktek is classified as Flexible keel whereas the SACH is Rigid.

b–j

Refer to the Supplier list.
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Author Manuscript

Six-minute walk test (6MWT) and step activity monitoring (ADSC) results
LA Foot
6MWT, m
ADSC, daily steps

ESAR Foot

% Correct Classification ESAR

% Correct Classification LA Foot

424.2 ± 21.1

422.7 ± 18.2

51.9

40.7

4955.0 ± 437.8

4660.0 ± 349.3

61.5

46.2

There were no significant differences between LA* and ESAR* level feet for either measure (α = 0.05).
Mean ± SE.

*

Classification based on Medicare Functional Classification Level system.
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